KIR3DL2

Download PDF

Recent Publications on KIR3DL2:
CD158k/KIR3DL2 is a useful marker for identifying neoplastic T-cells in Sezary syndrome by flow cytometry. Enumeration of neoplastic T-cells in peripheral blood specimens is...	5th June, 2008	Department of Pathology, University of Utah, Salt Lake City, Utah 84132,	Cytometry B Clin Cytom. 2008 May;74(3):156-62. DOI Direct Link
CD158K/KIR3DL2 transcript detection in lesional skin of patients with erythroderma is a tool for the diagnosis of Sezary syndrome. The distinction between Sezary syndrome (SS) and benign erythrodermic...	20th February, 2008	Department of Pathology, AP-HP, groupe hospitalier Henri Mondor-Albert	J Invest Dermatol. 2008 Feb;128(2):465-72. Epub 2007 Aug 16. DOI Direct Link
Polymorphisms of killer cell immunoglobulin-like receptor gene: possible association with susceptibility to or clearance of hepatitis B virus infection in Chinese Han population. AIM: To explore whether killer cell immunoglobulin-like receptors (KIR)...	11th January, 2008	Department of Center Laboratory, Shandong Provincial Hospital, Shandong	Croat Med J. 2007 Dec;48(6):800-6.
[Analysis of natural killer cell immunoglobulin-like receptor gene family in HLA-identical sibling] The aim of study was to analyze natural killer immunoglobulin (Ig)-like...	20th December, 2007	Blood Center of Zhejiang Province, Key Laboratory of Blood Safety	Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2007 Dec;15(6):1276-80.
[Study on the behavior of NK cell KIRs of donor/recipient pairs in HLA matched unrelated allo-HSCT] OBJECTIVE: To study the biological function of killer cell...	15th December, 2007	Jiangsu Institute of Hematology, First Affiliated Hospital of Soochow	Zhonghua Xue Ye Xue Za Zhi. 2007 Aug;28(8):510-3.
→View more research publications.

KIR3DL2 Patents:
US Patent No.	Title
7399595	Means for the diagnosis and therapy of CTCL
7235358	Methods and compositions for diagnosing and monitoring transplant rejection
7026121	Methods and compositions for diagnosing and monitoring transplant rejection
6905827	Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases

BioPortfolio Ltd. offers e-mail and postal lists for KIR3DL2 scientists - we have details of around 6 individuals working on KIR3DL2 .

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.